KIT and breast cancer: Notably, c-Kit-positive ovarian cancer cells showed higher autophagy levels (29), and c-Kit has been identified as an oncogenic driver and prognostic risk factor for various malignancies, including GIST, osteosarcoma, and ovarian cancer (30–32); however, its role in breast cancer remains unclear.